The University of Chicago Header Logo

Connection

Daniel Arber to Middle Aged

Back to Details
This is a "connection" page, showing publications Daniel Arber has written about Middle Aged.
Daniel Arber
Connection Strength
1.522
Middle Aged
  1. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. Mod Pathol. 2019 09; 32(9):1373-1385.
    View in: PubMed
    Score: 0.043
  2. Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH. Am J Surg Pathol. 2018 07; 42(7):885-890.
    View in: PubMed
    Score: 0.041
  3. Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis. Mod Pathol. 2017 03; 30(3):382-392.
    View in: PubMed
    Score: 0.037
  4. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance. Mod Pathol. 2016 09; 29(9):996-1003.
    View in: PubMed
    Score: 0.035
  5. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. Am J Clin Pathol. 2014 Dec; 142(6):803-8.
    View in: PubMed
    Score: 0.032
  6. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations. Mod Pathol. 2015 May; 28(5):706-14.
    View in: PubMed
    Score: 0.032
  7. Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings. Am J Clin Pathol. 2014 Aug; 142(2):190-5.
    View in: PubMed
    Score: 0.031
  8. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9.
    View in: PubMed
    Score: 0.031
  9. STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia. Leukemia. 2013 Nov; 27(11):2244-7.
    View in: PubMed
    Score: 0.028
  10. Bone marrow evaluation in new-onset pancytopenia. Hum Pathol. 2013 Jun; 44(6):1154-64.
    View in: PubMed
    Score: 0.028
  11. The prognostic value of CXCR4 in acute myeloid leukemia. Appl Immunohistochem Mol Morphol. 2013 Jan; 21(1):79-84.
    View in: PubMed
    Score: 0.028
  12. The differential diagnosis and bone marrow evaluation of new-onset pancytopenia. Am J Clin Pathol. 2013 Jan; 139(1):9-29.
    View in: PubMed
    Score: 0.028
  13. DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups. Br J Haematol. 2012 Oct; 159(2):182-90.
    View in: PubMed
    Score: 0.027
  14. Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies. Leukemia. 2011 Sep; 25(9):1439-43.
    View in: PubMed
    Score: 0.025
  15. Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue. Leuk Lymphoma. 2010 Jul; 51(7):1356-9.
    View in: PubMed
    Score: 0.023
  16. A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia. J Mol Diagn. 2009 Jul; 11(4):319-23.
    View in: PubMed
    Score: 0.022
  17. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol. 2009 Apr; 33(4):591-8.
    View in: PubMed
    Score: 0.022
  18. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood. 2009 Feb 26; 113(9):1906-8.
    View in: PubMed
    Score: 0.021
  19. The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas. J Mol Diagn. 2008 Nov; 10(6):502-12.
    View in: PubMed
    Score: 0.021
  20. Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: are immunohistochemical studies necessary? Hum Pathol. 2008 Sep; 39(9):1331-40.
    View in: PubMed
    Score: 0.020
  21. Features of hemolysis due to Clostridium perfringens infection. Int J Lab Hematol. 2009 Jun; 31(3):364-7.
    View in: PubMed
    Score: 0.020
  22. Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas. Appl Immunohistochem Mol Morphol. 2007 Mar; 15(1):1-7.
    View in: PubMed
    Score: 0.019
  23. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn. 2006 Sep; 8(4):466-75; quiz 527.
    View in: PubMed
    Score: 0.018
  24. Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias : report of six cases and review of literature. Am J Clin Pathol. 2006 Feb; 125(2):260-6.
    View in: PubMed
    Score: 0.017
  25. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol. 2005 Dec; 29(12):1549-57.
    View in: PubMed
    Score: 0.017
  26. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements. J Mol Diagn. 2005 Aug; 7(3):346-51.
    View in: PubMed
    Score: 0.017
  27. Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. Pediatr Blood Cancer. 2005 Mar; 44(3):270-6.
    View in: PubMed
    Score: 0.016
  28. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study. Am J Clin Pathol. 2024 Sep 03; 162(3):233-242.
    View in: PubMed
    Score: 0.016
  29. Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases. Haematologica. 2024 08 01; 109(8):2525-2532.
    View in: PubMed
    Score: 0.016
  30. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25; 391(4):320-333.
    View in: PubMed
    Score: 0.016
  31. Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
    View in: PubMed
    Score: 0.015
  32. STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia. Haematologica. 2024 06 01; 109(6):1825-1835.
    View in: PubMed
    Score: 0.015
  33. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis. Blood Cancer Discov. 2024 May 01; 5(3):164-179.
    View in: PubMed
    Score: 0.015
  34. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia. Hum Pathol. 2003 Aug; 34(8):809-13.
    View in: PubMed
    Score: 0.015
  35. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia. 2003 Jun; 17(6):1091-5.
    View in: PubMed
    Score: 0.014
  36. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. Am J Clin Pathol. 2003 May; 119(5):672-80.
    View in: PubMed
    Score: 0.014
  37. Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. Hum Pathol. 2003 May; 34(5):479-83.
    View in: PubMed
    Score: 0.014
  38. Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. Am J Clin Pathol. 2001 Jul; 116(1):25-33.
    View in: PubMed
    Score: 0.013
  39. Myeloid/lymphoid neoplasms with FLT3 rearrangement. Mod Pathol. 2021 09; 34(9):1673-1685.
    View in: PubMed
    Score: 0.012
  40. Keratin immunohistochemistry detects clinically significant metastases in bone marrow biopsy specimens in women with lobular breast carcinoma. Am J Surg Pathol. 2000 Dec; 24(12):1593-9.
    View in: PubMed
    Score: 0.012
  41. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol. 2000 Nov; 24(11):1511-7.
    View in: PubMed
    Score: 0.012
  42. CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mod Pathol. 2000 Nov; 13(11):1244-52.
    View in: PubMed
    Score: 0.012
  43. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Mod Pathol. 2021 01; 34(1):20-31.
    View in: PubMed
    Score: 0.012
  44. Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902. Transfusion. 2020 08; 60(8):1867-1872.
    View in: PubMed
    Score: 0.012
  45. Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy. Histopathology. 2020 06; 76(7):934-941.
    View in: PubMed
    Score: 0.012
  46. Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms. Am J Surg Pathol. 2000 May; 24(5):703-9.
    View in: PubMed
    Score: 0.012
  47. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol. 2020 07; 95(7):799-808.
    View in: PubMed
    Score: 0.012
  48. Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study. Int J Lab Hematol. 2020 Aug; 42(4):418-422.
    View in: PubMed
    Score: 0.012
  49. High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell Lymphoma Reveals Candidate Pathogenic Mutations. Appl Immunohistochem Mol Morphol. 2019 Nov/Dec; 27(10):740-748.
    View in: PubMed
    Score: 0.011
  50. Extranodal follicular dendritic cell tumor of the abdominal wall. J Clin Oncol. 1999 Jul; 17(7):2290-2.
    View in: PubMed
    Score: 0.011
  51. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions. Haematologica. 2019 10; 104(10):1935-1949.
    View in: PubMed
    Score: 0.011
  52. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol. 1999 Apr; 111(4):467-76.
    View in: PubMed
    Score: 0.011
  53. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. Am J Clin Pathol. 1999 Apr; 111(4):488-94.
    View in: PubMed
    Score: 0.011
  54. Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis. Cancer Genet Cytogenet. 1999 Feb; 109(1):58-65.
    View in: PubMed
    Score: 0.011
  55. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. Mod Pathol. 1998 Dec; 11(12):1211-21.
    View in: PubMed
    Score: 0.011
  56. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Mod Pathol. 2019 04; 32(4):490-498.
    View in: PubMed
    Score: 0.010
  57. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Mod Pathol. 2018 06; 31(6):873-880.
    View in: PubMed
    Score: 0.010
  58. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol. 1998 Feb; 109(2):211-20.
    View in: PubMed
    Score: 0.010
  59. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018 05; 31(5):690-704.
    View in: PubMed
    Score: 0.010
  60. Hepatosplenic gamma delta T-cell lymphoma--not just alphabet soup. Adv Anat Pathol. 1998 Jan; 5(1):21-9.
    View in: PubMed
    Score: 0.010
  61. Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol. 1997 Jul; 21(7):827-35.
    View in: PubMed
    Score: 0.010
  62. Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis. Am J Clin Pathol. 2017 Jul 01; 148(1):49-57.
    View in: PubMed
    Score: 0.010
  63. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Mod Pathol. 2017 09; 30(9):1213-1222.
    View in: PubMed
    Score: 0.009
  64. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017 08; 102(8):1352-1360.
    View in: PubMed
    Score: 0.009
  65. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia. Cancer Genet. 2017 Oct; 216-217:10-15.
    View in: PubMed
    Score: 0.009
  66. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia. Int J Lab Hematol. 2017 Aug; 39(4):375-383.
    View in: PubMed
    Score: 0.009
  67. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Am J Clin Pathol. 1997 Apr; 107(4):430-7.
    View in: PubMed
    Score: 0.009
  68. Splenic mesothelial cysts mimicking lymphagiomas. Am J Surg Pathol. 1997 Mar; 21(3):334-8.
    View in: PubMed
    Score: 0.009
  69. Presence of t(8;21)(q22;q22) in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia. Am J Clin Pathol. 1997 Jan; 107(1):68-73.
    View in: PubMed
    Score: 0.009
  70. Non-Hodgkin's lymphoproliferative disorders involving the spleen. Mod Pathol. 1997 Jan; 10(1):18-32.
    View in: PubMed
    Score: 0.009
  71. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996 Oct; 106(4):462-8.
    View in: PubMed
    Score: 0.009
  72. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia. Am J Pathol. 1996 Oct; 149(4):1105-10.
    View in: PubMed
    Score: 0.009
  73. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol. 1996 Jun; 27(6):590-4.
    View in: PubMed
    Score: 0.009
  74. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol. 2016 08; 29(8):854-64.
    View in: PubMed
    Score: 0.009
  75. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol. 2016 09; 55:39-43.
    View in: PubMed
    Score: 0.009
  76. An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified. Hum Pathol. 2016 Feb; 48:9-17.
    View in: PubMed
    Score: 0.008
  77. ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis. Blood. 2015 Nov 12; 126(20):2344-5.
    View in: PubMed
    Score: 0.008
  78. Surface Light Chain Expression in Primary Mediastinal Large B-Cell Lymphomas by Multiparameter Flow Cytometry. Am J Clin Pathol. 2015 Oct; 144(4):635-41.
    View in: PubMed
    Score: 0.008
  79. Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol. 1995 Oct; 26(10):1093-8.
    View in: PubMed
    Score: 0.008
  80. Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia. 2016 Apr; 30(4):947-50.
    View in: PubMed
    Score: 0.008
  81. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry. Am J Clin Pathol. 2015 Apr; 143(4):527-34.
    View in: PubMed
    Score: 0.008
  82. UCL3D3 and UCL4D12 reactivity in small B-cell neoplasms with special emphasis on monocytoid B-cell lymphoma. Hum Pathol. 1994 Oct; 25(10):1084-90.
    View in: PubMed
    Score: 0.008
  83. Reactive lymphoid hyperplasia of the terminal ileum: a benign (lymphoma-like) condition that may harbor aberrant immunohistochemical patterns or clonal immunoglobulin heavy chain gene rearrangements. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):585-92.
    View in: PubMed
    Score: 0.008
  84. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014 Apr 24; 123(17):2645-51.
    View in: PubMed
    Score: 0.008
  85. Non-Hodgkin's lymphoma involving the breast. Am J Surg Pathol. 1994 Mar; 18(3):288-95.
    View in: PubMed
    Score: 0.008
  86. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9.
    View in: PubMed
    Score: 0.008
  87. Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22). Am J Clin Pathol. 2013 Oct; 140(4):525-35.
    View in: PubMed
    Score: 0.007
  88. The bone marrow agar section: a morphologic and immunohistochemical evaluation. Mod Pathol. 1993 Sep; 6(5):592-8.
    View in: PubMed
    Score: 0.007
  89. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Adv Anat Pathol. 2013 May; 20(3):137-40.
    View in: PubMed
    Score: 0.007
  90. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993 Apr; 17(4):392-9.
    View in: PubMed
    Score: 0.007
  91. Vimentin-negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34. Am J Surg Pathol. 1993 Mar; 17(3):302-7.
    View in: PubMed
    Score: 0.007
  92. Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient. Am J Dermatopathol. 2013 Feb; 35(1):11-8.
    View in: PubMed
    Score: 0.007
  93. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2012 Nov; 36(11):1619-28.
    View in: PubMed
    Score: 0.007
  94. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am J Surg Pathol. 2012 May; 36(5):744-52.
    View in: PubMed
    Score: 0.007
  95. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol. 2012 Aug; 25(8):1128-39.
    View in: PubMed
    Score: 0.007
  96. Variation in reference cells for DNA analysis of paraffin-embedded tissue. Am J Clin Pathol. 1992 Mar; 97(3):387-92.
    View in: PubMed
    Score: 0.007
  97. Aneuploidy in benign seminal vesicle epithelium: an example of the paradox of ploidy studies. Mod Pathol. 1991 Nov; 4(6):687-9.
    View in: PubMed
    Score: 0.006
  98. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas. Am J Surg Pathol. 2011 Sep; 35(9):1373-80.
    View in: PubMed
    Score: 0.006
  99. The frequency of dual TCR-PCR clonality in granulomatous disorders. J Cutan Pathol. 2011 Sep; 38(9):704-9.
    View in: PubMed
    Score: 0.006
  100. Large-cell anaplastic (Ki-1-positive) lymphoma complicated by disseminated intravascular coagulation. Arch Pathol Lab Med. 1991 Feb; 115(2):188-92.
    View in: PubMed
    Score: 0.006
  101. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol. 2010 Aug; 85(8):600-6.
    View in: PubMed
    Score: 0.006
  102. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Leuk Res. 2010 May; 34(5):594-7.
    View in: PubMed
    Score: 0.006
  103. High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas. Am J Surg Pathol. 2009 Jun; 33(6):863-73.
    View in: PubMed
    Score: 0.005
  104. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. 2008 Oct; 30(5):425-30.
    View in: PubMed
    Score: 0.005
  105. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood. 2008 Jun 15; 111(12):5433-9.
    View in: PubMed
    Score: 0.005
  106. Lymphoplasmacytic lymphoma arising in the setting of hepatitis C and mixed cryoglobulinemia. J Clin Oncol. 2007 Sep 20; 25(27):4312-4.
    View in: PubMed
    Score: 0.005
  107. Fluorescence in situ hybridization investigation of cutaneous lesions in acute promyelocytic leukemia. Mod Pathol. 2005 Dec; 18(12):1569-76.
    View in: PubMed
    Score: 0.004
  108. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. J Clin Oncol. 2005 Sep 01; 23(25):6163-71.
    View in: PubMed
    Score: 0.004
  109. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood. 2005 Oct 15; 106(8):2865-70.
    View in: PubMed
    Score: 0.004
  110. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol. 2003 Feb 15; 21(4):615-23.
    View in: PubMed
    Score: 0.004
  111. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.
    View in: PubMed
    Score: 0.004
  112. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chromosomes Cancer. 2002 Apr; 33(4):379-94.
    View in: PubMed
    Score: 0.003
  113. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients. Leukemia. 2002 Apr; 16(4):623-31.
    View in: PubMed
    Score: 0.003
  114. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol. 2001 Nov; 14(11):1147-56.
    View in: PubMed
    Score: 0.003
  115. Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features. Histopathology. 2001 Nov; 39(5):476-81.
    View in: PubMed
    Score: 0.003
  116. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood. 2001 Jun 15; 97(12):3713-20.
    View in: PubMed
    Score: 0.003
  117. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 2001 May; 14(5):465-71.
    View in: PubMed
    Score: 0.003
  118. High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission. Leukemia. 2000 Jul; 14(7):1191-6.
    View in: PubMed
    Score: 0.003
  119. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 2000 Mar 01; 95(5):1588-93.
    View in: PubMed
    Score: 0.003
  120. The use of archival bone marrow specimens in detecting B-cell non-Hodgkin's lymphomas using polymerase chain reaction methods. Leuk Lymphoma. 2000 Jan; 36(3-4):347-52.
    View in: PubMed
    Score: 0.003
  121. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol. 1999 Nov; 23(11):1386-92.
    View in: PubMed
    Score: 0.003
  122. Soft tissue masses of the chest wall and axilla: has metastatic melanoma been considered? Am J Clin Oncol. 1999 Apr; 22(2):174-7.
    View in: PubMed
    Score: 0.003
  123. Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome. A report of five cases and review of the literature. Am J Clin Pathol. 1999 Mar; 111(3):373-8.
    View in: PubMed
    Score: 0.003
  124. Chromosome 11 abnormalities in Bowen disease of the vulva. Cancer Genet Cytogenet. 1997 Feb; 93(2):109-14.
    View in: PubMed
    Score: 0.002
  125. Pathologic features of nodular lymphocyte predominance Hodgkin's disease in extranodal sites. Am J Surg Pathol. 1995 Nov; 19(11):1313-24.
    View in: PubMed
    Score: 0.002
  126. Follicular small lymphocytic lymphoma. Am J Surg Pathol. 1994 Oct; 18(10):999-1009.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.